Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors

M Dehlin, L Jacobsson, E Roddy - Nature Reviews Rheumatology, 2020 - nature.com
Gout is the most common inflammatory arthritis and occurs when hyperuricaemia, sustained
elevation of serum urate levels resulting in supersaturation of body tissues with urate, leads …

[HTML][HTML] Gout: An old disease in new perspective–A review

G Ragab, M Elshahaly, T Bardin - Journal of advanced research, 2017 - Elsevier
Gout is a picturesque presentation of uric acid disturbance. It is the most well understood
and described type of arthritis. Its epidemiology is studied. New insights into the …

2020 American College of Rheumatology guideline for the management of gout

JD FitzGerald, N Dalbeth, T Mikuls… - Arthritis & …, 2020 - Wiley Online Library
Objective To provide guidance for the management of gout, including indications for and
optimal use of urate‐lowering therapy (ULT), treatment of gout flares, and lifestyle and other …

U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia

WT Crawley, CG Jungels, KR Stenmark, MA Fini - Redox Biology, 2022 - Elsevier
Serum uric acid (SUA) is significantly elevated in obesity, gout, type 2 diabetes mellitus, and
the metabolic syndrome and appears to contribute to the renal, cardiovascular and …

Physiology of hyperuricemia and urate-lowering treatments

CL Benn, P Dua, R Gurrell, P Loudon, A Pike… - Frontiers in …, 2018 - frontiersin.org
Gout is the most common form of inflammatory arthritis and is a multifactorial disease
typically characterized by hyperuricemia and monosodium urate crystal deposition …

Hyperuricemia and cardiovascular disease

S Zhang, Y Wang, J Cheng, N Huangfu… - Current …, 2019 - ingentaconnect.com
Purine metabolism in the circulatory system yields uric acid as its final oxidation product,
which is believed to be linked to the development of gout and kidney stones. Hyperuricemia …

Gout: state of the art after a decade of developments

T Pascart, F Lioté - Rheumatology, 2019 - academic.oup.com
This review article summarizes the relevant English literature on gout from 2010 through
April 2017. It emphasizes that the current epidemiology of gout indicates a rising prevalence …

Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update

AFG Cicero, F Fogacci, M Kuwabara, C Borghi - Medicina, 2021 - mdpi.com
This article aims to critically review the evidence on the available therapeutic strategies for
the treatment of hyperuricemia. For this reason, several papers were reviewed. Xanthine …

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care …

T Bardin, RT Keenan, PP Khanna, J Kopicko… - Annals of the …, 2017 - ard.bmj.com
Objectives Determine the efficacy and safety of daily lesinurad (200 or 400 mg orally) added
to allopurinol in patients with serum uric acid (sUA) above target in a 12-month, randomised …

Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities

LK Stamp, H Farquhar, HL Pisaniello… - Nature Reviews …, 2021 - nature.com
Gout and chronic kidney disease (CKD) frequently coexist, but quality evidence to guide
gout management in people with CKD is lacking. Use of urate-lowering therapy (ULT) in the …